Dr. Tandon is presently engaged in investing in healthcare and healthcare/IT in USA, UAE and India. Dr. Tandon has extensive board experience. She is currently Vice Chairman of the Board of El Camino Hospital, Silicon Valley, California and Chair of its Executive Compensation Committee and Vice-Chair of its Governance and Finance Committees. Additionally she has served on 12 high tech proprietary company boards in USA. Nandini’s past investments & Board roles include,IDUN (acquired by Pfizer), U-Systems (acquired by General Electric), KAI Pharmaceuticals (acquired by Amgen), Ception Therapeutics (acquired by Cephalon), Conforma Therapeutics (acquired by Biogen Idec), Corus Pharma (acquired by Gilead Sciences), AcordaTherapeutics (NASDAQ: ACOR), Alexza (NASDAQ: ALXA), Guava Technologies(acquired by Millipore), Ambit Biosciences, Saegis Pharmaceuticals and Cell Biosciences.Dr. Tandon has been a venture capitalist in Silicon Valley for past decade plus and was Managing Director, Lumira/MDS Capital in Palo Alto with 1.2 Billion dollar under management and before was Partner, Royal Bank of Canada’s RBC Capital Partners, in San Francisco.
She is on multiple not for profit boards which are committed to global innovation, entrepreneurship and healthcare including MD Anderson Center for Entrepreneurship and PD Board, Bay Area Council Economic Institute Board, University of California, Berkeley, Center for Emerging & Neglected Diseases Board, Chair,”20/20”Vision: Investing in USA & Emerging Markets”, C21 BioVentures Board, TiE Global Board, Stanford University, School of Medicine Career Center’s Advisory Council and San Francisco-Bangalore Sister City initiative’s board and co-Chair for its SF-India focus
Dr. Tandon is a strong champion for global investments in healthcare, entrepreneurship and innovation. She was delegate for President Obama’s US State Department’s Global Entrepreneurship program to Turkey, delegate for Secretary Hillary Clinton’s Women and Economy Summit, moderator for Healthcare focus of US Senator’s Congressional delegation to India, spoke at Milken Conference for Obama-Care and spoke at Clinton Global Initiative for Women in Technology, chaired investment focus for Super Return Conference in Geneva, San Francisco and Dubai, spoke at Secretary Geithner for US Department of Treasury’s symposium on Women in Finance(http://youtu.be/PH7eS4kt_FE) and recently co-chaired Healthcare delegation of Mayor of San Francisco to India. Nandini has strong operational experience as Chief Business Officer of Zyomyx Inc., Vice President of BD, Hyseq Inc. and BD Mangaer at Chiron Corp.. A White House Intern, Nandini received her Ph.D. in biochemistry, Phi Lambda Upsilon from Duke University, North Carolina and her B.A. cum laude, Sigma Xi, Phi Beta Kappa from Hollins University, Virginia.